Começar
ABBVIE INC CEDEAR EACH 10 REPR 1 COMABBVIE INC CEDEAR EACH 10 REPR 1 COMABBVIE INC CEDEAR EACH 10 REPR 1 COM

ABBVIE INC CEDEAR EACH 10 REPR 1 COM

Sem negociações
Veja nos super gráficos
Visão geral Finanças Notícias Ideias Discussions Sinais técnicos
Títulos

ABBV títulos

Abaixo está a lista de títulos corporativos ABBVIE INC CEDEAR EACH 10 REPR 1 COM. Os investidores geralmente optam pelos títulos de uma empresa por sua maior estabilidade em épocas de volatilidade do mercado. Estude preços, rendimentos e outras estatísticas e encontre um investimento confiável.
Símbolo
YTM %
Preço %
Cupom %
Data de vencimento
Montante em circulação
Valor de face
Valor mín. de denominação
Emissor
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,72%76,50%4,63%2042-10-0167,493 M USD1.000,00 USD2.000,00 USDActavis, Inc.
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
6,21%81,69%4,75%2045-03-1553,51 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
5,98%86,00%4,85%2044-06-1565,232 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,79%89,99%4,55%2035-03-15107,646 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,21%90,84%3,20%2029-11-2162,515 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,08%108,18%5,50%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
4,95%107,70%5,40%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
4,91%99,26%4,85%2044-06-151,008 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
AA5QDALLERGAN FNDG 15/25
4,90%98,93%3,80%2025-03-15130,225 M USD1.000,00 USD2.000,00 USDAllergan Funding SCS
US287YAW9ABBVIE 16/46
4,89%93,77%4,45%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBABBVIE 15/45
4,88%97,52%4,70%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
4,87%106,29%5,35%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
4,86%100,20%4,88%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
4,83%90,93%4,25%2049-11-215,745 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
4,80%94,91%4,40%2042-11-062,599 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
4,79%99,50%4,75%2045-03-15827,091 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
4,77%98,15%4,63%2042-10-01389,217 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
4,67%93,07%4,05%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
4,63%96,53%2,95%2026-11-219,245 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1ABBVIE 16/36
4,52%97,98%4,30%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4,47%100,72%4,55%2035-03-151,681 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0ABBVIE 15/35
4,44%100,48%4,50%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,39%105,21%5,05%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABCABBVIE 15/25
4,30%99,32%3,60%2025-05-143,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5083839AbbVie Inc. 3.8% 15-MAR-2025
4,21%99,60%3,80%2025-03-152,889 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,20%104,27%4,95%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,03%96,10%3,20%2029-11-215,437 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
4,01%103,26%4,80%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5ABBVIE 16/26
4,00%98,73%3,20%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XXS162262122ALLERGAN FNDG 17/29
3,92%92,27%2,13%2029-06-0136,462 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3,91%97,99%2,95%2026-11-213,991 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3,91%102,11%4,80%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3,90%101,36%4,25%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS190919331ALLERGAN FNDG 18/28
3,64%96,09%2,63%2028-11-1572,107 M EUR1.000,00 EUR100.000,00 EURAllergan Funding SCS
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,08%121,31%4,25%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,04%126,76%4,75%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5066461AbbVie Inc. 2.6% 21-NOV-2024
3,00%99,61%2,60%2024-11-213,739 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
2,97%128,71%4,85%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGABBVIE 19/31
2,93%89,10%1,25%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591483ABBVIE 20/28
2,82%99,23%2,63%2028-11-15427,793 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591491ABBVIE 20/29
2,80%97,01%2,13%2029-06-01506,088 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781ABBVIE 16/28
2,80%97,35%2,13%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
4ABEABBVIE 19/27
2,68%94,14%0,75%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,04%123,74%4,55%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4997740AbbVie Inc. 3.8% 15-MAR-2025
1,63%102,15%3,80%2025-03-151,268 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911714AbbVie Inc. 2.6% 21-NOV-2024
−3,63%106,34%2,60%2024-11-2110,86 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
——4,40%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5067241AbbVie Inc. 3.8% 15-MAR-2025
——3,80%2025-03-15—1.000,00 USD2.000,00 USDAbbVie, Inc.